Sitero has announced its recent acquisition of a technology suite designed to manage the end-to-end clinical trial lifecycle. The newly acquired eClinical technology suite, formerly of Clario, will be integrated with Sitero's existing Mentor platform with plans to invest in AI to further streamline the clinical trial process. This combined suite offers tools designed to enhance efficiency, accuracy, and quality of data across the site, CRO, and sponsor lifecycle of clinical trials.
Key components of the technology platform include:
The Clario eClinical product suite will be rebranded and integrated into the Sitero Mentor platform. Sitero Mentor will continue to support the existing Clario customer base while further developing clinical solutions for new customers as well.
Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery. (2023, August 1). Cision PR Newswire.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.